| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eye Proteins | 55 | 2012 | 160 | 5.860 |
Why?
|
| Retinal Cone Photoreceptor Cells | 35 | 2015 | 74 | 5.670 |
Why?
|
| Retinaldehyde | 63 | 2015 | 115 | 5.350 |
Why?
|
| Retinoids | 35 | 2016 | 122 | 4.820 |
Why?
|
| Rhodopsin | 63 | 2016 | 135 | 4.140 |
Why?
|
| Retinal Pigment Epithelium | 18 | 2017 | 145 | 2.990 |
Why?
|
| Retinal Rod Photoreceptor Cells | 28 | 2014 | 71 | 2.980 |
Why?
|
| Retinal Pigments | 37 | 2014 | 61 | 2.950 |
Why?
|
| Retina | 36 | 2017 | 252 | 2.550 |
Why?
|
| Lipofuscin | 11 | 2016 | 43 | 2.510 |
Why?
|
| Rod Opsins | 33 | 2010 | 59 | 2.510 |
Why?
|
| Vision, Ocular | 24 | 2014 | 68 | 2.430 |
Why?
|
| Carrier Proteins | 31 | 2012 | 597 | 2.360 |
Why?
|
| Vitamin A | 32 | 2015 | 111 | 2.240 |
Why?
|
| Bacteriorhodopsins | 26 | 2006 | 47 | 2.160 |
Why?
|
| Retinal Degeneration | 8 | 2013 | 75 | 1.790 |
Why?
|
| Retinol-Binding Proteins | 14 | 2011 | 28 | 1.730 |
Why?
|
| cis-trans-Isomerases | 30 | 2017 | 63 | 1.720 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 17 | 2017 | 306 | 1.490 |
Why?
|
| Light | 35 | 2012 | 152 | 1.490 |
Why?
|
| Animals | 164 | 2017 | 20880 | 1.400 |
Why?
|
| Macular Degeneration | 8 | 2017 | 75 | 1.250 |
Why?
|
| Proteins | 12 | 2005 | 473 | 1.150 |
Why?
|
| Transducin | 12 | 2011 | 31 | 1.100 |
Why?
|
| Pigment Epithelium of Eye | 13 | 2011 | 28 | 1.060 |
Why?
|
| Photoreceptor Cells | 21 | 2015 | 62 | 1.020 |
Why?
|
| Cattle | 50 | 2011 | 475 | 0.980 |
Why?
|
| Mice | 47 | 2017 | 8474 | 0.920 |
Why?
|
| Cone Opsins | 4 | 2011 | 9 | 0.920 |
Why?
|
| Regeneration | 4 | 2011 | 105 | 0.860 |
Why?
|
| Mice, Knockout | 27 | 2017 | 1692 | 0.850 |
Why?
|
| Aging | 11 | 2015 | 911 | 0.830 |
Why?
|
| Pyridinium Compounds | 5 | 2013 | 40 | 0.810 |
Why?
|
| Palmitic Acid | 6 | 2009 | 51 | 0.770 |
Why?
|
| Rod Cell Outer Segment | 21 | 2012 | 56 | 0.730 |
Why?
|
| Photoreceptor Cells, Vertebrate | 9 | 2014 | 46 | 0.710 |
Why?
|
| Dark Adaptation | 20 | 2012 | 39 | 0.660 |
Why?
|
| Superoxide Dismutase | 18 | 1993 | 149 | 0.660 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2014 | 167 | 0.660 |
Why?
|
| Protons | 9 | 2000 | 57 | 0.650 |
Why?
|
| Lens, Crystalline | 8 | 2006 | 39 | 0.650 |
Why?
|
| Electroretinography | 16 | 2011 | 122 | 0.640 |
Why?
|
| Mice, Inbred C57BL | 24 | 2017 | 2791 | 0.640 |
Why?
|
| Urodela | 13 | 2012 | 31 | 0.620 |
Why?
|
| Molecular Sequence Data | 30 | 2008 | 1446 | 0.580 |
Why?
|
| Ambystoma | 17 | 2014 | 33 | 0.570 |
Why?
|
| Photic Stimulation | 13 | 2014 | 229 | 0.550 |
Why?
|
| Amino Acid Sequence | 29 | 2008 | 1082 | 0.540 |
Why?
|
| Mutagenesis, Site-Directed | 14 | 2009 | 204 | 0.500 |
Why?
|
| Chromatography, High Pressure Liquid | 17 | 2017 | 381 | 0.490 |
Why?
|
| Acyltransferases | 5 | 2009 | 40 | 0.480 |
Why?
|
| Mass Spectrometry | 16 | 2010 | 284 | 0.460 |
Why?
|
| G-Protein-Coupled Receptor Kinase 1 | 2 | 2011 | 6 | 0.460 |
Why?
|
| Phosphatidylethanolamines | 1 | 2013 | 20 | 0.460 |
Why?
|
| Cornea | 6 | 1992 | 76 | 0.450 |
Why?
|
| Kinetics | 29 | 2012 | 1047 | 0.450 |
Why?
|
| Membrane Glycoproteins | 5 | 2006 | 370 | 0.430 |
Why?
|
| Oxidation-Reduction | 13 | 2012 | 567 | 0.410 |
Why?
|
| Proteoglycans | 2 | 2010 | 103 | 0.410 |
Why?
|
| Phosphorylation | 14 | 2010 | 1200 | 0.400 |
Why?
|
| Diterpenes | 12 | 2010 | 42 | 0.380 |
Why?
|
| Drug Inverse Agonism | 2 | 2010 | 7 | 0.380 |
Why?
|
| Retinal Dehydrogenase | 1 | 2010 | 10 | 0.370 |
Why?
|
| ATP-Binding Cassette Transporters | 6 | 2017 | 120 | 0.370 |
Why?
|
| COS Cells | 9 | 2010 | 155 | 0.360 |
Why?
|
| Laminin | 1 | 2010 | 62 | 0.360 |
Why?
|
| Sexual Harassment | 1 | 2010 | 12 | 0.360 |
Why?
|
| Models, Educational | 1 | 2010 | 67 | 0.350 |
Why?
|
| Humans | 57 | 2017 | 68549 | 0.350 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 2550 | 0.330 |
Why?
|
| Blindness | 2 | 2008 | 22 | 0.330 |
Why?
|
| Program Evaluation | 3 | 2010 | 502 | 0.320 |
Why?
|
| Hydroxylamine | 1 | 2008 | 9 | 0.320 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 236 | 0.320 |
Why?
|
| Education, Medical | 1 | 2010 | 147 | 0.320 |
Why?
|
| Pigments, Biological | 6 | 2005 | 15 | 0.310 |
Why?
|
| Health Surveys | 1 | 2010 | 488 | 0.310 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 281 | 0.310 |
Why?
|
| Emergency Service, Hospital | 5 | 2003 | 711 | 0.310 |
Why?
|
| Halobacterium salinarum | 8 | 2006 | 15 | 0.300 |
Why?
|
| Cysteine | 10 | 2009 | 112 | 0.300 |
Why?
|
| Opsins | 6 | 2014 | 19 | 0.300 |
Why?
|
| Tretinoin | 3 | 2003 | 92 | 0.300 |
Why?
|
| Arginine | 5 | 2000 | 102 | 0.300 |
Why?
|
| Halobacterium | 9 | 1997 | 16 | 0.300 |
Why?
|
| Collagen | 1 | 2010 | 636 | 0.290 |
Why?
|
| Blotting, Western | 10 | 2010 | 954 | 0.280 |
Why?
|
| Membrane Proteins | 6 | 2010 | 617 | 0.280 |
Why?
|
| Adaptation, Ocular | 2 | 2010 | 7 | 0.280 |
Why?
|
| Telephone | 3 | 2003 | 160 | 0.280 |
Why?
|
| Models, Molecular | 7 | 2009 | 546 | 0.270 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2010 | 710 | 0.260 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2005 | 22 | 0.260 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 7 | 2010 | 95 | 0.250 |
Why?
|
| Cells, Cultured | 9 | 2008 | 2673 | 0.250 |
Why?
|
| Kidney | 5 | 2009 | 945 | 0.250 |
Why?
|
| Spectrophotometry | 12 | 2006 | 54 | 0.250 |
Why?
|
| Xenopus laevis | 7 | 2010 | 60 | 0.240 |
Why?
|
| Alcohol Oxidoreductases | 5 | 2009 | 31 | 0.240 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 1293 | 0.240 |
Why?
|
| Lipids | 2 | 2017 | 298 | 0.240 |
Why?
|
| Species Specificity | 5 | 2013 | 302 | 0.240 |
Why?
|
| Aged, 80 and over | 13 | 2015 | 4843 | 0.240 |
Why?
|
| Models, Biological | 5 | 2015 | 981 | 0.240 |
Why?
|
| Darkness | 9 | 2007 | 27 | 0.240 |
Why?
|
| Circadian Rhythm | 1 | 2005 | 218 | 0.240 |
Why?
|
| Hydrogen Peroxide | 4 | 1993 | 168 | 0.230 |
Why?
|
| Rats | 25 | 2006 | 5300 | 0.230 |
Why?
|
| Norisoprenoids | 5 | 2010 | 7 | 0.230 |
Why?
|
| Peptide Fragments | 14 | 2006 | 483 | 0.230 |
Why?
|
| Binding Sites | 10 | 2009 | 631 | 0.230 |
Why?
|
| Lysine | 4 | 2004 | 96 | 0.220 |
Why?
|
| Eye | 6 | 2017 | 89 | 0.220 |
Why?
|
| Hotlines | 3 | 1998 | 51 | 0.220 |
Why?
|
| Hydrogen-Ion Concentration | 13 | 2000 | 618 | 0.220 |
Why?
|
| Base Sequence | 10 | 2006 | 1015 | 0.210 |
Why?
|
| Leber Congenital Amaurosis | 2 | 2011 | 7 | 0.200 |
Why?
|
| RNA, Messenger | 9 | 2010 | 1663 | 0.200 |
Why?
|
| Lipoylation | 3 | 2011 | 8 | 0.200 |
Why?
|
| Isomerism | 11 | 2007 | 63 | 0.190 |
Why?
|
| Structure-Activity Relationship | 11 | 2003 | 420 | 0.190 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 2 | 2012 | 19 | 0.190 |
Why?
|
| Mice, Transgenic | 5 | 2011 | 1033 | 0.190 |
Why?
|
| Child | 10 | 2013 | 6401 | 0.190 |
Why?
|
| Photochemistry | 14 | 1999 | 46 | 0.180 |
Why?
|
| Aquaporins | 5 | 2006 | 8 | 0.180 |
Why?
|
| Histidine | 1 | 2000 | 17 | 0.180 |
Why?
|
| Ultraviolet Rays | 5 | 2014 | 130 | 0.180 |
Why?
|
| Vitamin A Deficiency | 3 | 1989 | 11 | 0.180 |
Why?
|
| Catalase | 6 | 1991 | 85 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 7 | 2011 | 532 | 0.170 |
Why?
|
| Erythrocytes | 7 | 1997 | 137 | 0.170 |
Why?
|
| Superoxides | 3 | 1990 | 70 | 0.160 |
Why?
|
| Infant | 8 | 2013 | 2891 | 0.160 |
Why?
|
| Optic Nerve | 3 | 2017 | 55 | 0.160 |
Why?
|
| Protein Conformation | 9 | 2009 | 362 | 0.160 |
Why?
|
| Cell Count | 5 | 2011 | 248 | 0.160 |
Why?
|
| Child, Preschool | 8 | 2013 | 3187 | 0.160 |
Why?
|
| Molecular Structure | 5 | 2011 | 397 | 0.160 |
Why?
|
| Health Services Needs and Demand | 2 | 1996 | 149 | 0.160 |
Why?
|
| Streptozocin | 3 | 1983 | 34 | 0.160 |
Why?
|
| Stereoisomerism | 9 | 2011 | 169 | 0.160 |
Why?
|
| Monoglycerides | 1 | 2017 | 7 | 0.150 |
Why?
|
| Endosomes | 1 | 2017 | 45 | 0.150 |
Why?
|
| Time Factors | 14 | 2011 | 4655 | 0.150 |
Why?
|
| Sequence Alignment | 3 | 2006 | 165 | 0.150 |
Why?
|
| Counseling | 2 | 1997 | 279 | 0.150 |
Why?
|
| Triage | 4 | 2003 | 109 | 0.150 |
Why?
|
| Affinity Labels | 2 | 1994 | 66 | 0.150 |
Why?
|
| Carotenoids | 4 | 1986 | 45 | 0.150 |
Why?
|
| Consumer Behavior | 1 | 1997 | 68 | 0.150 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 562 | 0.150 |
Why?
|
| Lysosomes | 1 | 2017 | 136 | 0.140 |
Why?
|
| Lizards | 2 | 2006 | 8 | 0.140 |
Why?
|
| GTP-Binding Proteins | 4 | 1996 | 231 | 0.140 |
Why?
|
| Blotting, Southern | 5 | 2003 | 67 | 0.140 |
Why?
|
| Protein Structure, Secondary | 6 | 2003 | 136 | 0.140 |
Why?
|
| Mice, Mutant Strains | 3 | 2012 | 166 | 0.140 |
Why?
|
| Lysophospholipids | 1 | 2017 | 209 | 0.140 |
Why?
|
| Guanylate Cyclase | 5 | 2008 | 25 | 0.140 |
Why?
|
| Vision Disorders | 3 | 2017 | 94 | 0.140 |
Why?
|
| Microspectrophotometry | 5 | 2010 | 9 | 0.140 |
Why?
|
| Gene Expression | 6 | 2009 | 770 | 0.140 |
Why?
|
| Cell Membrane | 4 | 2012 | 524 | 0.130 |
Why?
|
| Remote Consultation | 1 | 1996 | 50 | 0.130 |
Why?
|
| Uveal Neoplasms | 2 | 2008 | 16 | 0.130 |
Why?
|
| Photolysis | 5 | 2006 | 16 | 0.130 |
Why?
|
| Molecular Weight | 4 | 2000 | 358 | 0.130 |
Why?
|
| Optical Imaging | 1 | 2016 | 46 | 0.130 |
Why?
|
| Glaucoma | 1 | 2016 | 50 | 0.130 |
Why?
|
| Adolescent | 10 | 2013 | 8904 | 0.130 |
Why?
|
| Fluorescence | 2 | 2014 | 104 | 0.130 |
Why?
|
| Cell Line | 3 | 2011 | 1752 | 0.130 |
Why?
|
| Male | 29 | 2011 | 37283 | 0.130 |
Why?
|
| Glutamic Acid | 2 | 1999 | 332 | 0.130 |
Why?
|
| Cloning, Molecular | 6 | 2004 | 357 | 0.120 |
Why?
|
| Cataract | 1 | 2016 | 134 | 0.120 |
Why?
|
| Circular Dichroism | 4 | 2006 | 99 | 0.120 |
Why?
|
| Crystallins | 3 | 1998 | 9 | 0.120 |
Why?
|
| Immunohistochemistry | 5 | 2014 | 1174 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 6 | 2012 | 261 | 0.120 |
Why?
|
| Spin Labels | 6 | 1997 | 27 | 0.120 |
Why?
|
| Aged | 13 | 2015 | 14842 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 4 | 2006 | 208 | 0.120 |
Why?
|
| Biophysics | 2 | 2010 | 41 | 0.120 |
Why?
|
| In Vitro Techniques | 12 | 2010 | 765 | 0.120 |
Why?
|
| Proteomics | 2 | 2014 | 246 | 0.120 |
Why?
|
| Glutathione Peroxidase | 2 | 1991 | 39 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2005 | 337 | 0.110 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2003 | 48 | 0.110 |
Why?
|
| Parents | 1 | 1996 | 309 | 0.110 |
Why?
|
| Electrophysiology | 6 | 2009 | 160 | 0.110 |
Why?
|
| Cell Survival | 5 | 2011 | 901 | 0.110 |
Why?
|
| Recombinant Proteins | 4 | 2009 | 742 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 333 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2005 | 284 | 0.110 |
Why?
|
| Metamorphosis, Biological | 2 | 2010 | 4 | 0.110 |
Why?
|
| London | 3 | 1997 | 12 | 0.110 |
Why?
|
| Infant, Newborn | 4 | 2013 | 2455 | 0.110 |
Why?
|
| Female | 20 | 2011 | 38021 | 0.110 |
Why?
|
| GTP-Binding Protein alpha Subunits | 2 | 2010 | 12 | 0.110 |
Why?
|
| Protein Binding | 7 | 2010 | 1027 | 0.110 |
Why?
|
| Cross-Linking Reagents | 3 | 2006 | 80 | 0.110 |
Why?
|
| Albumins | 1 | 1992 | 72 | 0.110 |
Why?
|
| Adult | 15 | 2013 | 21379 | 0.110 |
Why?
|
| Alloxan | 2 | 1982 | 3 | 0.100 |
Why?
|
| Melanoma | 2 | 2008 | 335 | 0.100 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 2 | 2005 | 31 | 0.100 |
Why?
|
| Visual Perception | 2 | 2011 | 124 | 0.100 |
Why?
|
| Molecular Conformation | 5 | 2009 | 128 | 0.100 |
Why?
|
| Middle Aged | 13 | 2013 | 21119 | 0.100 |
Why?
|
| Hydrolases | 2 | 2008 | 20 | 0.100 |
Why?
|
| Schiff Bases | 3 | 2000 | 12 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2009 | 1745 | 0.100 |
Why?
|
| Arrestin | 1 | 2011 | 12 | 0.100 |
Why?
|
| Young Adult | 2 | 2013 | 5710 | 0.100 |
Why?
|
| Islets of Langerhans | 2 | 1982 | 87 | 0.100 |
Why?
|
| Tears | 1 | 1991 | 9 | 0.100 |
Why?
|
| Rats, Inbred Strains | 8 | 1991 | 532 | 0.090 |
Why?
|
| Amino Acid Substitution | 3 | 2006 | 137 | 0.090 |
Why?
|
| Injections, Intraperitoneal | 1 | 2010 | 89 | 0.090 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 87 | 0.090 |
Why?
|
| Mutation | 6 | 2010 | 1213 | 0.090 |
Why?
|
| Delayed-Action Preparations | 1 | 2010 | 120 | 0.090 |
Why?
|
| Choroid | 3 | 2005 | 22 | 0.090 |
Why?
|
| DNA, Complementary | 3 | 2003 | 251 | 0.090 |
Why?
|
| Gender Identity | 1 | 2010 | 47 | 0.090 |
Why?
|
| Water | 3 | 2008 | 228 | 0.090 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 64 | 0.090 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2000 | 22 | 0.090 |
Why?
|
| Light Signal Transduction | 1 | 2009 | 6 | 0.090 |
Why?
|
| Chromatography, Ion Exchange | 2 | 2006 | 73 | 0.090 |
Why?
|
| Aspartic Acid | 3 | 2000 | 65 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2010 | 304 | 0.090 |
Why?
|
| Nitroso Compounds | 1 | 1989 | 16 | 0.080 |
Why?
|
| Benzenesulfonates | 1 | 1989 | 30 | 0.080 |
Why?
|
| Membrane Potentials | 4 | 2006 | 200 | 0.080 |
Why?
|
| Purple Membrane | 2 | 2000 | 3 | 0.080 |
Why?
|
| Spectrum Analysis | 4 | 2006 | 81 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2010 | 202 | 0.080 |
Why?
|
| Biological Transport | 3 | 2005 | 210 | 0.080 |
Why?
|
| Haplorhini | 1 | 2008 | 44 | 0.080 |
Why?
|
| NADP | 2 | 2006 | 39 | 0.080 |
Why?
|
| Referral and Consultation | 4 | 2003 | 383 | 0.080 |
Why?
|
| Vitamins | 1 | 2009 | 134 | 0.080 |
Why?
|
| Electron Spin Resonance Spectroscopy | 7 | 1997 | 28 | 0.080 |
Why?
|
| Biomarkers | 1 | 2013 | 1593 | 0.080 |
Why?
|
| Models, Chemical | 3 | 2003 | 155 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2005 | 272 | 0.080 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2008 | 85 | 0.070 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 3 | 2006 | 18 | 0.070 |
Why?
|
| Rabbits | 6 | 2008 | 509 | 0.070 |
Why?
|
| Epithelium | 4 | 1990 | 172 | 0.070 |
Why?
|
| Hair Color | 1 | 2006 | 4 | 0.070 |
Why?
|
| Pigmentation | 1 | 2006 | 12 | 0.070 |
Why?
|
| Peptide Mapping | 3 | 2005 | 39 | 0.070 |
Why?
|
| Rana pipiens | 3 | 2007 | 11 | 0.070 |
Why?
|
| Hospitals, Urban | 2 | 1996 | 46 | 0.070 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 1986 | 4 | 0.070 |
Why?
|
| Pharmaceutic Aids | 1 | 1986 | 7 | 0.070 |
Why?
|
| Intermediate Filament Proteins | 1 | 2006 | 12 | 0.070 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 223 | 0.070 |
Why?
|
| RNA | 2 | 2005 | 171 | 0.070 |
Why?
|
| Hemolysis | 2 | 1997 | 39 | 0.070 |
Why?
|
| Transfection | 2 | 2009 | 782 | 0.070 |
Why?
|
| Proton Pumps | 2 | 1997 | 13 | 0.070 |
Why?
|
| Ferrous Compounds | 1 | 2005 | 18 | 0.070 |
Why?
|
| Incidence | 1 | 2010 | 1582 | 0.070 |
Why?
|
| Visual Pathways | 1 | 2005 | 31 | 0.070 |
Why?
|
| Salicylates | 2 | 1997 | 22 | 0.070 |
Why?
|
| Ion Channels | 1 | 2005 | 72 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2005 | 447 | 0.060 |
Why?
|
| Injections | 2 | 2003 | 119 | 0.060 |
Why?
|
| Receptors, Cell Surface | 2 | 2008 | 248 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2000 | 2083 | 0.060 |
Why?
|
| Health Services Misuse | 2 | 2003 | 15 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2008 | 230 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 4 | 2003 | 492 | 0.060 |
Why?
|
| Esters | 3 | 2017 | 22 | 0.060 |
Why?
|
| Larva | 4 | 2009 | 39 | 0.060 |
Why?
|
| Copper | 3 | 2000 | 149 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 219 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 508 | 0.060 |
Why?
|
| Collagen Type XVIII | 1 | 2003 | 2 | 0.060 |
Why?
|
| Caveolins | 1 | 2003 | 6 | 0.060 |
Why?
|
| Dogs | 6 | 1985 | 490 | 0.060 |
Why?
|
| Neuroglia | 1 | 2004 | 136 | 0.060 |
Why?
|
| Endostatins | 1 | 2003 | 11 | 0.060 |
Why?
|
| Protein Array Analysis | 1 | 2003 | 32 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 1983 | 195 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 3 | 2003 | 511 | 0.060 |
Why?
|
| Deuterium Oxide | 3 | 1999 | 6 | 0.060 |
Why?
|
| Cellular Senescence | 1 | 2004 | 112 | 0.060 |
Why?
|
| Luciferases | 1 | 2003 | 105 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 3 | 2011 | 112 | 0.060 |
Why?
|
| Caveolin 1 | 1 | 2003 | 59 | 0.060 |
Why?
|
| Hydroxylamines | 2 | 1995 | 20 | 0.060 |
Why?
|
| South Carolina | 1 | 2010 | 2752 | 0.060 |
Why?
|
| Antigens | 1 | 2003 | 90 | 0.060 |
Why?
|
| Cystine | 1 | 2003 | 20 | 0.060 |
Why?
|
| Zinc | 2 | 1985 | 73 | 0.050 |
Why?
|
| Emergency Medical Service Communication Systems | 1 | 2003 | 25 | 0.050 |
Why?
|
| Ambulances | 1 | 2003 | 27 | 0.050 |
Why?
|
| Microelectrodes | 2 | 2014 | 16 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1996 | 507 | 0.050 |
Why?
|
| Heart, Artificial | 2 | 1992 | 2 | 0.050 |
Why?
|
| Dirofilaria immitis | 2 | 1993 | 6 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2003 | 132 | 0.050 |
Why?
|
| Color | 3 | 2012 | 50 | 0.050 |
Why?
|
| Serine | 2 | 2005 | 99 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2003 | 75 | 0.050 |
Why?
|
| Retinitis Pigmentosa | 1 | 1982 | 17 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2003 | 489 | 0.050 |
Why?
|
| Apoptosis | 1 | 2009 | 1641 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2003 | 312 | 0.050 |
Why?
|
| Emergency Nursing | 2 | 2003 | 9 | 0.050 |
Why?
|
| DNA Primers | 3 | 1996 | 302 | 0.050 |
Why?
|
| Histocytochemistry | 4 | 2005 | 149 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 614 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2014 | 139 | 0.050 |
Why?
|
| Spectrophotometry, Ultraviolet | 5 | 2005 | 79 | 0.050 |
Why?
|
| Phenylurea Compounds | 1 | 1981 | 31 | 0.050 |
Why?
|
| Liposomes | 4 | 2000 | 107 | 0.050 |
Why?
|
| Azides | 2 | 1999 | 56 | 0.050 |
Why?
|
| Solubility | 2 | 2012 | 134 | 0.050 |
Why?
|
| Rats, Mutant Strains | 1 | 2000 | 14 | 0.050 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2000 | 28 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 5 | 2008 | 196 | 0.050 |
Why?
|
| Free Radicals | 6 | 1997 | 65 | 0.050 |
Why?
|
| Microscopy, Electron | 3 | 2009 | 351 | 0.050 |
Why?
|
| Deamination | 1 | 2000 | 4 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2000 | 36 | 0.040 |
Why?
|
| Adaptation, Physiological | 3 | 1999 | 189 | 0.040 |
Why?
|
| Cyanogen Bromide | 4 | 2005 | 14 | 0.040 |
Why?
|
| Onchocerca | 2 | 1990 | 4 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 1999 | 45 | 0.040 |
Why?
|
| Etoposide | 1 | 1999 | 64 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 1999 | 100 | 0.040 |
Why?
|
| Models, Structural | 2 | 1996 | 22 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 3 | 1994 | 219 | 0.040 |
Why?
|
| Oxygen | 4 | 2000 | 386 | 0.040 |
Why?
|
| Cytomegalovirus Infections | 1 | 1999 | 69 | 0.040 |
Why?
|
| Community Health Nursing | 1 | 1998 | 14 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 1999 | 181 | 0.040 |
Why?
|
| Nerve Degeneration | 2 | 2010 | 134 | 0.040 |
Why?
|
| Tryptophan | 1 | 1998 | 65 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 1999 | 223 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1997 | 12 | 0.040 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2009 | 11 | 0.040 |
Why?
|
| Chromatography, Affinity | 2 | 2009 | 73 | 0.040 |
Why?
|
| State Medicine | 1 | 1997 | 7 | 0.040 |
Why?
|
| Algorithms | 2 | 2005 | 1195 | 0.040 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1997 | 11 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2010 | 7268 | 0.040 |
Why?
|
| Temperature | 2 | 1997 | 340 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 1999 | 211 | 0.040 |
Why?
|
| Guanidine | 1 | 1997 | 7 | 0.040 |
Why?
|
| Night Care | 1 | 1997 | 4 | 0.040 |
Why?
|
| Guanidines | 1 | 1997 | 32 | 0.040 |
Why?
|
| Dapsone | 1 | 1997 | 21 | 0.040 |
Why?
|
| Rodentia | 1 | 2017 | 27 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 1997 | 66 | 0.040 |
Why?
|
| Disulfides | 1 | 1997 | 40 | 0.040 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 35 | 0.040 |
Why?
|
| Subcellular Fractions | 2 | 2008 | 92 | 0.040 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1996 | 8 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 1997 | 239 | 0.030 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1996 | 48 | 0.030 |
Why?
|
| Kallikrein-Kinin System | 1 | 1996 | 18 | 0.030 |
Why?
|
| Amino Acids | 3 | 2003 | 131 | 0.030 |
Why?
|
| Hospitals, Public | 1 | 1996 | 22 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 1997 | 177 | 0.030 |
Why?
|
| Photobleaching | 2 | 2006 | 3 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1996 | 167 | 0.030 |
Why?
|
| Immunoblotting | 2 | 2009 | 254 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 322 | 0.030 |
Why?
|
| Diabetic Retinopathy | 1 | 1996 | 110 | 0.030 |
Why?
|
| Emergencies | 1 | 1996 | 107 | 0.030 |
Why?
|
| Data Collection | 1 | 1997 | 420 | 0.030 |
Why?
|
| Macaca | 1 | 2015 | 24 | 0.030 |
Why?
|
| Membranes | 3 | 2009 | 26 | 0.030 |
Why?
|
| Escherichia coli | 2 | 1994 | 368 | 0.030 |
Why?
|
| Age Distribution | 1 | 1996 | 319 | 0.030 |
Why?
|
| Health Services Research | 1 | 1996 | 209 | 0.030 |
Why?
|
| Bruch Membrane | 2 | 2005 | 6 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1995 | 45 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 2 | 2004 | 48 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 186 | 0.030 |
Why?
|
| Serpins | 1 | 1996 | 205 | 0.030 |
Why?
|
| Lasers | 3 | 1992 | 61 | 0.030 |
Why?
|
| Microsomes | 2 | 2005 | 31 | 0.030 |
Why?
|
| Chromogenic Compounds | 1 | 1994 | 3 | 0.030 |
Why?
|
| Nurse-Patient Relations | 1 | 1994 | 34 | 0.030 |
Why?
|
| Cyclotrons | 1 | 2014 | 3 | 0.030 |
Why?
|
| Oocytes | 2 | 2005 | 57 | 0.030 |
Why?
|
| Retinal Neurons | 1 | 2014 | 9 | 0.030 |
Why?
|
| Fourier Analysis | 1 | 2014 | 31 | 0.030 |
Why?
|
| Chromatography, Liquid | 2 | 2004 | 120 | 0.030 |
Why?
|
| Nursing Staff, Hospital | 1 | 1994 | 62 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2004 | 89 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 1753 | 0.030 |
Why?
|
| Alanine | 1 | 1993 | 38 | 0.030 |
Why?
|
| Serum Albumin | 1 | 1993 | 104 | 0.030 |
Why?
|
| Tissue Distribution | 3 | 2004 | 282 | 0.030 |
Why?
|
| Isoelectric Point | 1 | 1992 | 9 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 1992 | 25 | 0.030 |
Why?
|
| Palmitic Acids | 1 | 1992 | 15 | 0.030 |
Why?
|
| Primary Health Care | 1 | 1998 | 702 | 0.030 |
Why?
|
| Oleic Acid | 2 | 2009 | 40 | 0.030 |
Why?
|
| Hemodynamics | 2 | 1992 | 705 | 0.030 |
Why?
|
| Vitamin E | 1 | 1992 | 55 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 201 | 0.030 |
Why?
|
| Solvents | 3 | 1999 | 109 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 1992 | 122 | 0.030 |
Why?
|
| Serum Albumin, Bovine | 2 | 2004 | 43 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2006 | 791 | 0.030 |
Why?
|
| Glioblastoma | 1 | 1995 | 219 | 0.030 |
Why?
|
| Tyrosine | 1 | 1992 | 196 | 0.030 |
Why?
|
| Xanthine Oxidase | 2 | 1990 | 15 | 0.030 |
Why?
|
| Trypsin | 2 | 2004 | 64 | 0.030 |
Why?
|
| Apoproteins | 2 | 2003 | 11 | 0.030 |
Why?
|
| Hydroxyl Radical | 3 | 1998 | 17 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 44 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 61 | 0.020 |
Why?
|
| Oxides | 1 | 2011 | 47 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 1994 | 442 | 0.020 |
Why?
|
| Anemia, Hemolytic | 1 | 1991 | 37 | 0.020 |
Why?
|
| Night Vision | 1 | 2010 | 2 | 0.020 |
Why?
|
| Vision Tests | 1 | 2010 | 18 | 0.020 |
Why?
|
| Cell Size | 1 | 2010 | 76 | 0.020 |
Why?
|
| Cyclic N-Oxides | 3 | 1997 | 17 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 120 | 0.020 |
Why?
|
| Contrast Sensitivity | 1 | 2010 | 28 | 0.020 |
Why?
|
| Zidovudine | 1 | 1990 | 27 | 0.020 |
Why?
|
| Chickens | 2 | 2003 | 232 | 0.020 |
Why?
|
| Ciliary Body | 2 | 2003 | 52 | 0.020 |
Why?
|
| Tritium | 2 | 1989 | 101 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2010 | 190 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2010 | 63 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2009 | 43 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2009 | 87 | 0.020 |
Why?
|
| Periodicity | 1 | 1989 | 43 | 0.020 |
Why?
|
| Substrate Specificity | 2 | 2003 | 234 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 160 | 0.020 |
Why?
|
| Reactive Oxygen Species | 2 | 2005 | 499 | 0.020 |
Why?
|
| Decision Support Techniques | 2 | 2003 | 191 | 0.020 |
Why?
|
| Vertebrates | 2 | 2003 | 20 | 0.020 |
Why?
|
| Electrophoresis | 1 | 1989 | 69 | 0.020 |
Why?
|
| Oleic Acids | 1 | 1988 | 40 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 1988 | 37 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2009 | 311 | 0.020 |
Why?
|
| Ligands | 1 | 2009 | 317 | 0.020 |
Why?
|
| Vitreous Body | 2 | 1999 | 26 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 1988 | 31 | 0.020 |
Why?
|
| Endothelium, Corneal | 1 | 1988 | 20 | 0.020 |
Why?
|
| Fenretinide | 1 | 1988 | 26 | 0.020 |
Why?
|
| Evoked Potentials, Visual | 1 | 2007 | 18 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2008 | 246 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 280 | 0.020 |
Why?
|
| Point Mutation | 2 | 1998 | 97 | 0.020 |
Why?
|
| Catalysis | 2 | 1999 | 123 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 183 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2006 | 62 | 0.020 |
Why?
|
| Thymidine | 1 | 1986 | 32 | 0.020 |
Why?
|
| Cricetinae | 1 | 2006 | 262 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2009 | 384 | 0.020 |
Why?
|
| Macrophages | 1 | 2010 | 647 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 1996 | 201 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2006 | 27 | 0.020 |
Why?
|
| Cytotoxins | 1 | 1986 | 23 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2006 | 59 | 0.020 |
Why?
|
| Action Potentials | 2 | 1994 | 223 | 0.020 |
Why?
|
| Microphthalmos | 1 | 2005 | 9 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2005 | 47 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2005 | 57 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 307 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 71 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2005 | 84 | 0.020 |
Why?
|
| Gene Library | 1 | 2005 | 68 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 1988 | 431 | 0.020 |
Why?
|
| Capillaries | 1 | 2005 | 105 | 0.020 |
Why?
|
| Kallikreins | 2 | 1996 | 323 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2005 | 24 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2005 | 204 | 0.020 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2004 | 9 | 0.020 |
Why?
|
| Immunodiffusion | 1 | 1984 | 19 | 0.020 |
Why?
|
| Threonine | 1 | 2005 | 47 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1984 | 57 | 0.020 |
Why?
|
| Cytophotometry | 1 | 2004 | 3 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 16 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1984 | 164 | 0.020 |
Why?
|
| Asparagine | 1 | 2004 | 15 | 0.020 |
Why?
|
| Muscles | 1 | 1985 | 158 | 0.020 |
Why?
|
| Electrodes | 1 | 2005 | 147 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2005 | 161 | 0.020 |
Why?
|
| Glycosylation | 1 | 2005 | 185 | 0.020 |
Why?
|
| Acetylation | 1 | 2004 | 94 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 67 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2004 | 144 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2004 | 99 | 0.010 |
Why?
|
| Nanotechnology | 1 | 2005 | 109 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 155 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2003 | 49 | 0.010 |
Why?
|
| Glutathione | 2 | 1997 | 343 | 0.010 |
Why?
|
| Computers | 1 | 1984 | 63 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 320 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1984 | 282 | 0.010 |
Why?
|
| Glycosuria | 1 | 1983 | 2 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2003 | 92 | 0.010 |
Why?
|
| Permeability | 1 | 2003 | 131 | 0.010 |
Why?
|
| Surface Properties | 1 | 2004 | 363 | 0.010 |
Why?
|
| Albinism | 1 | 2003 | 3 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1983 | 75 | 0.010 |
Why?
|
| Retinol-Binding Proteins, Cellular | 1 | 2003 | 2 | 0.010 |
Why?
|
| Choroid Neoplasms | 1 | 2003 | 20 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2003 | 71 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2003 | 71 | 0.010 |
Why?
|
| Ketones | 1 | 2003 | 24 | 0.010 |
Why?
|
| England | 1 | 2003 | 64 | 0.010 |
Why?
|
| Allied Health Personnel | 1 | 2003 | 37 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 498 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2003 | 152 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2002 | 98 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2003 | 222 | 0.010 |
Why?
|
| Peptides | 1 | 1984 | 455 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 448 | 0.010 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2001 | 10 | 0.010 |
Why?
|
| Calcium | 1 | 2005 | 929 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2003 | 652 | 0.010 |
Why?
|
| Skin | 1 | 2003 | 451 | 0.010 |
Why?
|
| Phenanthrolines | 1 | 2000 | 5 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 2000 | 45 | 0.010 |
Why?
|
| Microfilariae | 2 | 1990 | 2 | 0.010 |
Why?
|
| Absorption | 1 | 1999 | 49 | 0.010 |
Why?
|
| Mitochondria, Liver | 1 | 1981 | 148 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 13 | 0.010 |
Why?
|
| Quantum Theory | 1 | 1999 | 20 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 659 | 0.010 |
Why?
|
| Age Factors | 1 | 1984 | 1860 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1999 | 121 | 0.010 |
Why?
|
| Organometallic Compounds | 1 | 2000 | 95 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1999 | 60 | 0.010 |
Why?
|
| Titrimetry | 1 | 1999 | 11 | 0.010 |
Why?
|
| Mathematical Computing | 1 | 1999 | 12 | 0.010 |
Why?
|
| Visual Cortex | 1 | 1980 | 67 | 0.010 |
Why?
|
| Nitroblue Tetrazolium | 1 | 1978 | 2 | 0.010 |
Why?
|
| 5-Hydroxytryptophan | 1 | 1998 | 4 | 0.010 |
Why?
|
| Electrophoresis, Disc | 1 | 1978 | 11 | 0.010 |
Why?
|
| Cyanides | 1 | 1978 | 15 | 0.010 |
Why?
|
| Methionine | 1 | 1998 | 36 | 0.010 |
Why?
|
| Glutamine | 1 | 1999 | 45 | 0.010 |
Why?
|
| Goldfish | 1 | 1998 | 11 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1998 | 11 | 0.010 |
Why?
|
| Nursing Evaluation Research | 1 | 1998 | 46 | 0.010 |
Why?
|
| Fishes | 1 | 1978 | 77 | 0.010 |
Why?
|
| Kynurenine | 1 | 1998 | 36 | 0.010 |
Why?
|
| Gamma Rays | 1 | 1998 | 64 | 0.010 |
Why?
|
| Phylogeny | 1 | 1998 | 196 | 0.010 |
Why?
|
| Cysteamine | 1 | 1997 | 5 | 0.010 |
Why?
|
| Electrochemistry | 1 | 1997 | 70 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1999 | 244 | 0.010 |
Why?
|
| Hydroxylation | 1 | 1997 | 41 | 0.010 |
Why?
|
| Lighting | 1 | 1976 | 9 | 0.010 |
Why?
|
| DNA Probes | 1 | 1996 | 57 | 0.010 |
Why?
|
| Information Systems | 1 | 1997 | 45 | 0.010 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 1996 | 25 | 0.010 |
Why?
|
| Receptors, Bradykinin | 1 | 1996 | 50 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1997 | 120 | 0.010 |
Why?
|
| Kininogens | 1 | 1996 | 88 | 0.010 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 1996 | 75 | 0.010 |
Why?
|
| Phenotype | 1 | 1998 | 946 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1995 | 14 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1995 | 32 | 0.010 |
Why?
|
| Terpenes | 1 | 1994 | 18 | 0.010 |
Why?
|
| Exons | 1 | 1995 | 122 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1995 | 122 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1995 | 160 | 0.010 |
Why?
|
| Blood Pressure | 2 | 1992 | 1449 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1995 | 294 | 0.010 |
Why?
|
| Cell Division | 1 | 1995 | 541 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1993 | 27 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 852 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1993 | 30 | 0.010 |
Why?
|
| Reference Standards | 1 | 1993 | 115 | 0.010 |
Why?
|
| Ethanol | 1 | 1999 | 892 | 0.010 |
Why?
|
| Reaction Time | 1 | 1993 | 170 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 37 | 0.010 |
Why?
|
| Thermolysin | 1 | 1992 | 3 | 0.010 |
Why?
|
| Dimyristoylphosphatidylcholine | 1 | 1992 | 4 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1992 | 38 | 0.010 |
Why?
|
| Biomedical Engineering | 1 | 1992 | 20 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 1992 | 33 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1993 | 86 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 95 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1992 | 162 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 1992 | 130 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 1992 | 190 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 1992 | 301 | 0.010 |
Why?
|
| Glucose Oxidase | 1 | 1990 | 2 | 0.010 |
Why?
|
| Rose Bengal | 1 | 1990 | 3 | 0.010 |
Why?
|
| Hydroxides | 1 | 1990 | 5 | 0.010 |
Why?
|
| Singlet Oxygen | 1 | 1990 | 2 | 0.010 |
Why?
|
| Xanthine | 1 | 1990 | 14 | 0.010 |
Why?
|
| Xanthines | 1 | 1990 | 17 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1990 | 21 | 0.010 |
Why?
|
| Thiourea | 1 | 1990 | 16 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1990 | 62 | 0.010 |
Why?
|
| Glucuronidase | 1 | 1990 | 11 | 0.010 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1990 | 25 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 1990 | 31 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1990 | 44 | 0.010 |
Why?
|
| Biotransformation | 1 | 1990 | 69 | 0.010 |
Why?
|
| DNA | 1 | 1993 | 597 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 1994 | 467 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1989 | 32 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1997 | 3703 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1990 | 346 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 1988 | 79 | 0.000 |
Why?
|
| Movement | 1 | 1989 | 179 | 0.000 |
Why?
|
| Formaldehyde | 1 | 1985 | 48 | 0.000 |
Why?
|
| Rana catesbeiana | 1 | 1984 | 5 | 0.000 |
Why?
|
| Endocrine Glands | 1 | 1983 | 7 | 0.000 |
Why?
|
| Digestive System | 1 | 1983 | 35 | 0.000 |
Why?
|
| Respiratory System | 1 | 1983 | 28 | 0.000 |
Why?
|
| Actins | 1 | 1985 | 249 | 0.000 |
Why?
|
| Central Nervous System | 1 | 1983 | 107 | 0.000 |
Why?
|
| Scattering, Radiation | 1 | 1976 | 30 | 0.000 |
Why?
|
| Mathematics | 1 | 1976 | 83 | 0.000 |
Why?
|